Once-daily Oral Modified Release Hydrocortisone in Patients With Adrenal Insufficiency
Status:
Completed
Trial end date:
2009-01-28
Target enrollment:
Participant gender:
Summary
This is a randomised, controlled, open, two-armed, two-period cross-over, multi-centre phase
II/III study to assess the safety, tolerability and pharmacokinetics of once-daily oral
modified-release hydrocortisone in comparison to conventional thrice-daily oral
hydrocortisone tablets in patients with adrenal insufficiency